The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

The FDA has approved Yeztugo (lenacapvir), a twice-yearly injection to prevent HIV infection that could improve adherence ...

WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...

In two recent studies, this new shot reportedly nearly eliminated new infections in people at substantial risk of HIV.

Learning the best type of HIV prevention for those at highest risk can start with conversations about their options, writes ...

Clinical trials have shown that six-monthly injections of lenacapavir are almost 100 percent protective against becoming ...

The twice-yearly shot lenacapavir, sold under the name Yeztugo, reportedly nearly eliminated new HIV infections in studies of ...

Researchers from MIT and Scripps have unveiled a promising new HIV vaccine approach that generates a powerful immune response ...

The approval could slow new infections and move the world closer to eliminating HIV. But huge obstacles remain.

Yeztugo showed promising results in clinical trials. One study involving women in Africa reported 100% efficacy, with zero ...